Comparison · NCT03860818-sae
Intervention Arm vs Control Arm: serious adverse events
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Intervention Arm vs Control Arm: serious adverse events. Trial comparisons, record NCT03860818-sae. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03860818-sae
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.335 | 0.31 | 0.362 | wilson | |
| Risk in group 2 | 0.46 | 0.427 | 0.493 | wilson | |
| Risk difference, group 1 minus group 2 | -0.124 | -0.166 | -0.0828 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.729 | 0.657 | 0.81 | log | |
| Odds ratio, group 1 over group 2 | 0.593 | 0.498 | 0.706 | log | |
| Number needed to treat, for one fewer participant with a serious adverse event on Intervention Arm than on Control Arm | 8.04 | 6.03 | 12.1 | from the risk difference interval |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: control.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Intervention Arm | Technology-enabled pharmacist intervention~Health services delivery: Technology-enabled pharmacist intervention | 436 | 1,300 | EG001 |
| Group 2 | Control Arm | Usual Care, no intervention.~The control arm received usual care. Usual care for veteran organ transplant recipients across the 10 study sites is not standardized but generally includes the following: at most sites, nurse coordinators and/ or midlevel practitioners are responsible for general transplant patient oversight, including ensuring laboratory assessments are scheduled/reviewed and medication regimens are accurate and up to date. However, large patient numbers and workload constraints preclude these health care professionals from prospective detailed daily monitoring of patients. Within usual follow-up care, pharmacists do not conduct routine daily surveillance of all transplant patients | 412 | 896 | EG000 |
Source ClinicalTrials.gov
Harm
- What it counts
- Total, serious adverse events
- Time frame
- 27-month study period
Source ClinicalTrials.gov
Trial
- Title
- Improving Transplant Medication Safety Through A Technology and Pharmacist Intervention
- NCT number
- NCT03860818
- Phases
- NA
- Conditions
- Transplant
- Interventions
- Health services delivery
- Lead sponsor
- VA Office of Research and Development
- Results first posted
- 2024-08-01
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT03860818?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT03860818-sae